ctrl K

Price Alert

Alzamend Neuro Inc. (ALZN)

NASDAQ: ALZN · Real-Time Price · USD

2.35

-0.02 (-0.84%)

At close: Sep 10, 2025, 3:59 PM

2.35

0.21%

After-hours: Sep 10, 2025, 07:46 PM EDT

Alzamend Neuro Balance Sheet Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	376.05K	5.14M	14.06M	1.93M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	-0.00	0.00	352.5K
Receivables	n/a	n/a	n/a	16.21K
Inventory	n/a	n/a	n/a	-16.21K
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	455.24K	5.84M	14.41M	2.91M
Property-Plant & Equipment	176.35K	79.84K	102.91K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	176.35K	79.84K	102.91K	352.5K
Total Assets	631.59K	5.92M	14.52M	2.91M
Account Payables	2.93M	2.87M	1.16M	503.59K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	300.71K	n/a	n/a	335.3K
Other Current Liabilities	n/a	n/a	n/a	n/a
Total Current Liabilities	3.23M	2.87M	1.16M	899.64K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	0.00	n/a	n/a	n/a
Total Long-Term Liabilities	0.00	n/a	1.16M	n/a
Total Liabilities	3.23M	2.87M	1.16M	899.64K
Total Debt	300.71K	n/a	n/a	335.3K
Common Stock	69.00	9.69K	9.55K	6.74K
Retained Earnings	-54.02M	-44.07M	-29.19M	-16.83M
Comprehensive Income	n/a	-14.88M	-14.88M	-14.88M
Shareholders Equity	-2.59M	3.05M	13.35M	2.01M
Total Investments	n/a	n/a	n/a	n/a